The diagnosis of thymoma and thymic atrophy in patients with myasthenia gravis;Diagnostikk av tymom og thymusatrofi hos pasienter med myasthenia gravis

Tidsskrift for den Norske Laegeforening

Volumn 117, Issue 29, 1997, Pages 4212-4214

  Sund, Ketil Kvanum ^a   Skeie, Geir Olve ^a   Gilhus, Nils Erik ^a   Aarli, Johan A ^a   Varhaug, Jan Erik ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G;

ADULT; AGED; ARTICLE; ATROPHY; FEMALE; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; PATHOLOGY; THYMECTOMY; THYMOMA; THYMUS;

ADULT; AGED; ATROPHY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; THYMECTOMY; THYMOMA; THYMUS GLAND; THYMUS NEOPLASMS;

EID: 0031592125     PISSN: 00292001     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Storm-Mathisen A. Myasthenia gravis. Tidsskr Nor Lægeforen 1992; 112: 1574-8.
2. Phillips LH, Torner JC, Anderson MS, Cox GM. The epidemiology of myasthenia gravis in central and western Virginia. Neurology 1992; 42: 1888-93.
3. Thorlacius S, Aarli JA, Ruse T, Matre R, Johnsen HJ. Associated disorders in myasthenia gravis; autoimmune diseases and their relation to thymectomy. Acta Neurol Scand 1989; 80: 290-5.
4. Gilhus NE, Willcox N, Harcourt G, Nagvekar N, Beeson D, Vincent A et al. Antigen presentation by thymoma epithelial cells from myasthenia gravis patients to potentially pathogenic T cells. J Neuroimmunol 1995; 56: 65-76.
5. Castleman B. The pathology of the thymus gland in myasthenia gravis. Ann N Y Acad Sci 1966; 135: 496-505.
6. Keynes G. Investigations into thymic disease and tumor formation. Br J Surg 1955; 42: 449-62.
7. Alpert LI, Papatestas A, Kark A, Osserman RS, Osserman K. A histological reappraisal of the thymus in myasthenia gravis. A correlative study of thymic pathology and response to thymectomy. Arch Pathol 1971; 91: 55-61.
8. Oosterhuis HJGH. Myasthenia gravis. New York: Churchill Livingstone, 1984.
9. Mygland Å, Aarli JA, Matre R, Gilhus NE. Ryanodine receptor antibodies related to severity of thymoma associated myasthenia gravis. J Neurol Neurosurg Psychiatry 1994; 57: 843-6.
10. Jaretzki A, Bethea M, Wollf M, Olarte MR, Lovelace R, Penn AS et al. A rational approach to total thymectomy in the treatment of myasthenia gravis. Ann Thorac Surg 1977; 24: 120-30.
11. Fumes A, Halvorsen JF, Varhaug JE, Gilhus NE, Aarli JA, Husby P et al. Tymektomi ved myasthenia gravis. Tidsskr Nor Lægeforen 1988; 108: 1199-202.
12. Bolooki H, Schwartzman RJ. High-dose steroids for perioperative management of patients with myasthenia gravis undergoing thymectomy. A preliminary report. J Thorac Cardiovasc Surg 1978; 75: 754-7.
13. Lefvert AK, Bergström K, Matell G, Osterman PO, Pirskanen R. Determination of acetylcholinereceptor in myasthenia gravis - clinical usefullness and pathologic implications. J Neurol Neurosurg Psychiatry 1978; 41: 394-403.
14. Aarli JA. Localization and properties of an acid-soluble muscle antigen reacting with autoantibodies in myasthenia gravis sera. Acta Pathol Microbiol Scand B Microbiol Immunol 1972; 80: 453-9.
15. Gautel M, Lakey A, Barlow DP, Holmes Z, Scales S, Leonard K et al. Titin antibodies in myasthenia gravis: identification of a major immunogenic region of titin. Neurology 1993; 43: 1581-5.
16. Gilhus NE, Matre R, Aarli JA, Hofstad H, Thunold S. Thymic lymphoepitheliomas and skeletal muscle expressing common antigen(s). Acta Neurol Scand 1886; 73: 428-33.
17. Aarli JA. Myasthenia gravis and thymoma. I: Lisak RP, red. Handbook of myasthenia gravis and myasthenic syndromes. New York: Marcel Dekker, 1994: 207-24.
18. Keynes G. The results of thymectomy in myasthenia gravis. BJM 1949; 2: 611-6.
19. Compston DA, Vincent A, Newsom-Davis J, Batchelor JR. Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in myasthenia gravis. Brain 1980; 103: 579-601.
20. Aarli JA, Gilhus NE, Matre R. Myasthenia gravis with thymoma is not associated with an increased incidence of non-muscle autoimmune disorders. Autoimmunity 1992; 11: 159-62.
21. Aarli JA, Stefansson K, Marton LS, Wollmann RL. Patients with myasthenia gravis have in their sera IgG autoantibodies against titin. Clin Exp Immunol 1990; 82: 284-8.
22. Somniér FE, Trojaborg W. Neurophysiological evaluation in myasthenia gravis. A comprehensive study of a complete patient population. Electroencephalogr Clin Neurophysiol 1993; 89: 73-87.
23. Skeie GO, Mygland Å, Aarli JA, Gilhus NE. Titin antibodies in late onset myasthenia gravis: clinical correlations. Autoimmunity 1995; 20: 99-104.
24. Spurkland A, Gilhus NE, Rønningen KS, Aarli JA, Vartdal F. Myasthenia patients with thymus hyperplasia and myasthnia gravis patients with thymoma display different HLA association. Tissue Antigens 1991; 37: 90-3.
25. Carlsson B, Wallin J, Pirskanen R, Matell G, Smith E. Different HLA DR-DQ associations in subgroups of ideopathic myasthenia gravis. Immunogenetics 1990; 31: 285-90.
26. Tregnaghi A, De Candia A, Calderone M, Talenti E, Sartori V, Bonifatti DM et al. Imaging of the thymus gland in myasthenia gravis (computerized tomography and magnetic resonance). Radiol Med (Torino) 1995; 90: 404-9.
27. Emskotter T, Trampe H, Lachenmayer L. Magnetic resonance imaging in myasthenia gravis. An alternative to mediastinal computerized tomography? Dtsch Med Wochenschr 1988; 113: 1508-10.
28. Walter E, Willich E, Webb W. The thymus. Heidelberg: Springer-Verlag, 1992.